Background: This investigation evaluates the safety and feasibility of a TPF induction therapy under pegfilgrastim protection with a subsequent concomitant radioimmunochemotherapy using cetuximab and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback